PKG inhibitor peptide
Based on 2 publication(s) in Google Scholar
PKG inhibitor peptide is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.81%
- CAS 番号: 82801-73-8
- 分子式: C38H74N18O10
- 分子量:943.11
-
保管条件:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-P1561
PKG SubstratePKG Substrate -
HY-N6789
KT5720PKA Inhibitor -
HY-P0221
PACAP (1-38), human, ovine, ratPACAP Agonist -
HY-P0176
PACAP (1-27), human, ovine, ratPACAP Receptor Agonist -
HY-12306A
8-Bromo-cAMPPKA Activator -
HY-111759
JaspamycinPKA Activator -
HY-P1291
PKI 14-22 amide,myristoylatedPKA Inhibitor -
HY-P1290
PKA Inhibitor Fragment (6-22) amidePKA Inhibitor -
HY-P0248
KemptidePKA Substrate -
HY-P0222
PKI(5-24)PKA Inhibitor -
HY-100530
Rp-cAMPS triethylammonium saltPKA I/II Antagonist -
HY-110221
Rp-8-pCPT-cGMPS sodiumPKG Inhibitor
MedChemExpress（MCE）の使用を引用している文献 PKG inhibitor peptide
More
生物活性
製品説明
IC50 & Target
Ki: 86 μM (PKG)[1]
体外実験
Summary of experiments showing that intracellular dialysis of postsynaptic cells with PKG inhibitor PKG inhibitor peptide (1 mM) failed to alter the induction of long-term depression (CCh-LTD)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 82801-73-8
-
性状 Solid
-
分子量 943.11
-
分子式 C38H74N18O10
-
Color White to off-white
-
シーケンスの短縮
RKRARKE
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Sep;645(8079):244-253. PMID: 40562926 -
Oncogene
LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy. [Abstract]2025 Jul 28. PMID: 40721659
溶剤 & 溶解度
体外:
DMSO : ≥ 100 mg/mL (106.03 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 100 mg/mL (106.03 mM; Need ultrasonic)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
体内:
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (106.03 mM); Clear solution; Need ultrasonic
純度とドキュメンテーション
-
データシート (273 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Bhatnagar D, et al. Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry. 1988 Mar 22;27(6):1988-94. [Content Brief]
[2]. Chiung-Chun Huang, et al. Activation of muscarinic acetylcholine receptors induces a nitric oxide-dependent long-term depression in rat medial prefrontal cortex. Cereb Cortex. 2010 Apr;20(4):982-96. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO / H2O | 1 mM | 1.0603 mL | 5.3016 mL | 10.6032 mL | 26.5080 mL |
| 5 mM | 0.2121 mL | 1.0603 mL | 2.1206 mL | 5.3016 mL | |
| 10 mM | 0.1060 mL | 0.5302 mL | 1.0603 mL | 2.6508 mL | |
| 15 mM | 0.0707 mL | 0.3534 mL | 0.7069 mL | 1.7672 mL | |
| 20 mM | 0.0530 mL | 0.2651 mL | 0.5302 mL | 1.3254 mL | |
| 25 mM | 0.0424 mL | 0.2121 mL | 0.4241 mL | 1.0603 mL | |
| 30 mM | 0.0353 mL | 0.1767 mL | 0.3534 mL | 0.8836 mL | |
| 40 mM | 0.0265 mL | 0.1325 mL | 0.2651 mL | 0.6627 mL | |
| 50 mM | 0.0212 mL | 0.1060 mL | 0.2121 mL | 0.5302 mL | |
| 60 mM | 0.0177 mL | 0.0884 mL | 0.1767 mL | 0.4418 mL | |
| 80 mM | 0.0133 mL | 0.0663 mL | 0.1325 mL | 0.3314 mL | |
| 100 mM | 0.0106 mL | 0.0530 mL | 0.1060 mL | 0.2651 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
PKG inhibitor peptide 関連分類
HY-P1292 関連分類
Powered by Bioz